Teva shed 37% of Israel workforce in two years - Globes
Israel's Teva seeks partners for new drugs to relieve pressure | Reuters
EU accuses Teva Pharmaceutical of anti-competitive behaviour | Financial Times
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Teva leans on Ajovy and Austedo as revenues sink
Teva abused patent system and spread misinformation about a Copaxone rival, European officials say
TEVA stock on watch after EU approval for biosimilar to Roche's Lucentis (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
UPDATED: Teva builds injectables plant in Russia with Nanolek | Fierce Pharma
Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm - Pharmaceutical Technology
TEVA stock as EU cites antitrust concerns over multiple sclerosis therapy (NYSE:TEVA) | Seeking Alpha
Why Europe's drug shortages may get worse | Article | China Daily
Anything but Generic: A map for Selling to Teva Pharmaceuticals
Teva Pharmaceuticals Europe - With #ERSCongress 2019 approaching, the Let's Talk Respiratory team want to give you a flavour of things to come. From Q&As, symposiums, and a booth we know you'll
Teva reports jump in first-quarter earnings, raises guidance | The Times of Israel
Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21, 2019 | JewishPress.com
European Commission preliminary report says Teva violated antitrust rules
Why Europe's drug shortages may get worse | Reuters
What To Do After EU Hits Teva With Antitrust Concerns (NYSE:TEVA) | Seeking Alpha
Teva: 'Celltrion deal will double biosimilar sales to $600m'
Teva Pharmaceuticals - Wikipedia
Fallout from Teva plant closings, global layoffs continues in Israel | Fierce Pharma
